UK experience of ofatumumab in recurrence of focal segmental glomerulosclerosis post-kidney transplant

Reynolds, B. C., Lamb, A., Jones, C. A., Yadav, P., Tyerman, K. S. and Geddes, C. C. (2022) UK experience of ofatumumab in recurrence of focal segmental glomerulosclerosis post-kidney transplant. Pediatric Nephrology, 37(1), pp. 199-207. (doi: 10.1007/s00467-021-05248-9) (PMID:34383125) (PMCID:PMC8674165)

[img] Text
249062.pdf - Published Version
Available under License Creative Commons Attribution.

695kB

Abstract

Background: Steroid-resistant nephrotic syndrome (SRNS), commonly caused by focal segmental glomerulosclerosis (FSGS), is associated with progression to stage 5 chronic kidney disease, requirement for kidney replacement therapy and a risk of disease recurrence post-kidney transplantation. Ofatumumab (OFA) is a fully humanised monoclonal antibody to CD20, with similar mechanisms of action to rituximab (RTX). Methods: We report a case series of seven UK patients (five paediatric, two adult), all of whom developed FSGS recurrence after kidney transplantation and received OFA as part of their therapeutic intervention. All also received concomitant plasmapheresis. The 2-year outcome of these seven patients is reported, describing clinical course, kidney function and proteinuria. Results: Four patients (all paediatric) achieved complete urinary remission with minimal proteinuria 12 months post-treatment. Three of those four also had normal graft function. Two patients showed partial remission—brief improvement to non-nephrotic proteinuria (197 mg/mmol) in one patient, maintained improvement in kidney function (estimated glomerular filtration rate 76 ml/min/1.73 m2) in the other. One patient did not demonstrate any response. Conclusions: OFA may represent a useful addition to therapeutic options in the management of FSGS recurrence post-transplantation, including where RTX has shown no benefit. Concomitant plasmapheresis in all patients prevents any definitive conclusion that OFA was the beneficial intervention.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Geddes, Dr Colin and Reynolds, Dr Ben
Authors: Reynolds, B. C., Lamb, A., Jones, C. A., Yadav, P., Tyerman, K. S., and Geddes, C. C.
College/School:College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:Pediatric Nephrology
Publisher:Springer
ISSN:0931-041X
ISSN (Online):1432-198X
Published Online:12 August 2021
Copyright Holders:Copyright © 2021 The Authors
First Published:First published in Pediatric Nephrology 37(1): 199-207
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record